KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Astrana Health (ASTH) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Astrana Health (ASTH) over the last 17 years, with Q3 2025 value amounting to 2.01%.

  • Astrana Health's EBITDA Margin fell 39300.0% to 2.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.1%, marking a year-over-year decrease of 28200.0%. This contributed to the annual value of 4.39% for FY2024, which is 17100.0% down from last year.
  • Astrana Health's EBITDA Margin amounted to 2.01% in Q3 2025, which was down 39300.0% from 3.11% recorded in Q2 2025.
  • Astrana Health's 5-year EBITDA Margin high stood at 23.41% for Q3 2021, and its period low was 1.1% during Q4 2023.
  • For the 5-year period, Astrana Health's EBITDA Margin averaged around 7.22%, with its median value being 6.18% (2024).
  • Within the past 5 years, the most significant YoY rise in Astrana Health's EBITDA Margin was 97300bps (2021), while the steepest drop was -134800bps (2021).
  • Astrana Health's EBITDA Margin (Quarter) stood at 1.15% in 2021, then soared by 271bps to 4.28% in 2022, then crashed by -126bps to 1.1% in 2023, then skyrocketed by 110bps to 0.11% in 2024, then soared by 1756bps to 2.01% in 2025.
  • Its EBITDA Margin stands at 2.01% for Q3 2025, versus 3.11% for Q2 2025 and 3.32% for Q1 2025.